WALSH COLIN
CIK 1866174
Transactions on file
54
Open-market buys
4
Win rate (buys)
100%
4 scored
Avg % since filing (buys)
+36.0%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-28 | 2026-08-06 | ATTO Attovia Therapeutics, Inc. | Director | Buy | 500,000 | $8.50M | +50.3% | open → |
| 2026-08-28 | 2026-08-06 | ATTO Attovia Therapeutics, Inc. | Director | C | 478,498 | $0.00 | — | open → |
| 2026-08-28 | 2026-08-06 | ATTO Attovia Therapeutics, Inc. | Director | C | 1,957,134 | $0.00 | — | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 76,418 | $1.61M | +21.4% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 6,763 | $146.1K | +18.2% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 100 | $2.2K | +16.2% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 1,163 | $25.8K | +15.1% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 700 | $15.4K | +15.8% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 200 | $4.4K | +15.9% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 443 | $9.6K | +17.3% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 300 | $6.3K | +22.6% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 1,040 | $22.9K | +15.9% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 1,180 | $25.8K | +17.0% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 400 | $8.8K | +16.0% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 6,970 | $153.5K | +16.0% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 672 | $14.8K | +16.0% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 753 | $16.5K | +16.3% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 100 | $2.2K | +15.6% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 480 | $10.3K | +18.6% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 200 | $4.4K | +15.6% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 3,402 | $74.9K | +16.0% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 1,556 | $34.3K | +15.8% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 200 | $4.4K | +15.9% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 1,332 | $29.3K | +16.0% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 447 | $9.8K | +16.8% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 988 | $21.8K | +16.0% | open → |
| 2026-08-28 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Buy | 85,000 | $1.78M | +21.7% | open → |
| 2026-08-14 | 2026-08-06 | ATTO Attovia Therapeutics, Inc. | Director | Buy | 500,000 | $8.50M | +50.3% | open → |
| 2026-08-14 | 2026-08-06 | ATTO Attovia Therapeutics, Inc. | Director | C | 478,498 | $0.00 | — | open → |
| 2026-08-14 | 2026-08-06 | ATTO Attovia Therapeutics, Inc. | Director | C | 1,957,134 | $0.00 | — | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 76,418 | $1.61M | +21.4% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 6,763 | $146.1K | +18.2% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 100 | $2.2K | +16.2% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 1,163 | $25.8K | +15.1% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 700 | $15.4K | +15.8% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 200 | $4.4K | +15.9% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 443 | $9.6K | +17.3% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 300 | $6.3K | +22.6% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 1,040 | $22.9K | +15.9% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 1,180 | $25.8K | +17.0% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 400 | $8.8K | +16.0% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 6,970 | $153.5K | +16.0% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 672 | $14.8K | +16.0% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 753 | $16.5K | +16.3% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 100 | $2.2K | +15.6% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 480 | $10.3K | +18.6% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 200 | $4.4K | +15.6% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 3,402 | $74.9K | +16.0% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 1,556 | $34.3K | +15.8% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 200 | $4.4K | +15.9% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 1,332 | $29.3K | +16.0% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 447 | $9.8K | +16.8% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Sale | 988 | $21.8K | +16.0% | open → |
| 2026-08-14 | 2026-08-05 | ATTO Attovia Therapeutics, Inc. | Director | Buy | 85,000 | $1.78M | +21.7% | open → |
